442
Views
18
CrossRef citations to date
0
Altmetric
ARTICLE

The Role of Palliative External Beam Radiation Therapy in Boney Metastases Pain Management

, &
Pages 28-34 | Received 26 Sep 2012, Accepted 06 Dec 2012, Published online: 08 Feb 2013

REFERENCES

  • Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–593.
  • Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2).
  • Decroisette C, Monnet I, Berard H, Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601). J Thorac Oncol. 2011;6(3):576–582.
  • Sher DJ. Cost-effectiveness studies in radiation therapy. Expert Rev Pharmacoecon Outcomes Res. 2010;10(5):567–582.
  • Greco C, Forte L, Erba P, Mariani G. Bone metastases, general and clinical issues. Q J Nucl Med Mol Imaging. 2011;55(4):337–352.
  • Gralow JR, Biermann JS, Farooki A, NCCN task force report: bone health in cancer care. J Natl Compr Canc Netw. 2009;7(Suppl 3):S1–S32; quiz S33–S35.
  • Yu HH, Tsai YY, Hoffe SE. Overview of diagnosis and management of metastatic disease to bone. Cancer Control. 2012;19(2):84–91.
  • Smith HS. Painful osseous metastases. Pain Physician. 2011;14(4):E373–E403.
  • Fitch M, Maxwell C, Ryan C, Lothman H, Drudge-Coates L, Costa L. Bone metastases from advanced cancers: clinical implications and treatment options. Clin J Oncol Nurs. 2009;13(6):701–710.
  • Lipton A. Treatment of bone metastases and bone pain with bisphosphonates. Support Cancer Ther. 2007;4(2):92–100.
  • Janjan NA, Payne R, Gillis T, Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage. 1998;16(3):171–178.
  • Zeng L, Chow E, Bedard G, Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys. 2012;84(3):e337–e342.
  • Delea T, McKiernan J, Brandman J, Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol. 2006;4(7):341–347.
  • Lage MJ, Barber BL, Harrison DJ, Jun S. The cost of treating skeletal-related events in patients with prostate cancer. Am J Manag Care. 2008;14(5):317–322.
  • Delea T, Langer C, McKiernan J, The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology. 2004;67(5–6):390–396.
  • Janjan N. Bone metastases: approaches to management. Semin Oncol. 2001;28(4 Suppl 11):28–34.
  • Rolfs RT, Johnson E, Williams NJ, Sundwall DN. Utah clinical guidelines on prescribing opioids for treatment of pain. J Pain Pall Care Pharmacother. 2010;24(3):219–235.
  • McNicol E. Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. J. Pain Pall Care Pharmacother. 2008;22(4):270–281.
  • Eustice C. The facts of analgesics (painkillers). 2008; Available at: http://arthritis.about.com/od/analgesic/a/factsanalgesics. htm.
  • Cleeland CS, Gonin R, Hatfield AK, Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330(9):592–596.
  • Aapro M, Saad F, Costa L. Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. Oncologist. 2010;15(11):1147–1158.
  • Burkiewicz JS, Scarpace SL, Bruce SP. Denosumab in osteoporosis and oncology. Ann Pharmacother. 2009;43(9): 1445–1455.
  • Groot MT, Boeken Kruger CG, Pelger RC, Uyl-de Groot CA. Costs of prostate cancer, metastatic to the bone, in the Netherlands. Eur Urol. 2003;43(3):226–232.
  • Lutz S, Berk L, Chang E, Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79(4):965–976.
  • Bese NS, Kiel K, El-Gueddari Bel K, Campbell OB, Awuah B, Vikram B. Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J. 2006;12(Suppl 1):S96–S102.
  • Sejpal SV, Bhate A, Small W. Palliative radiation therapy in the management of brain metastases, spinal cord compression, and bone metastases. Semin Intervent Radiol. 2007;24(4):363–374.
  • Di Lorenzo G, Autorino R, Ciardiello F, External beam radiotherapy in bone metastatic prostate cancer: impact on patients’ pain relief and quality of life. Oncol Rep. 2003;10(2):399–404.
  • Mandoliti G, Polico C, Capirci C, Radiation therapy of bone metastases in the elderly: a multicentric survey of the Italian “Geriatric Radiation Oncology Group.” Rays. 1997;22(1 Suppl):57–60.
  • Chow E, Davis L, Holden L, A comparison of radiation therapy outcomes of bone metastases employing international consensus endpoints and traditional endpoints. Supportive Cancer Therapy. 2004;1(3):173–178.
  • Falkmer U, Jarhult J, Wersall P, Cavallin-Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol. 2003;42(5–6):620–633.
  • Huisman M, van den Bosch MA, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2012;84(1):8–14.
  • Hayashi S, Hoshi H, Iida T, Kajiura Y. Multi-fractionated wide-field radiation therapy for palliation of multiple symptomatic bone metastases from solid tumors. Radiat Med. 1999;17(6):411–416.
  • Haley ML, Gerszten PC, Heron DE, Chang YF, Atteberry DS, Burton SA. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis. J Neurosurg Spine. 2011;14(4):537–542.
  • Chow E, Hruby G, Davis L, Quality of life after local external beam radiation therapy for symptomatic bone metastases: a prospective evaluation. Support Cancer Ther. Apr 1 2004;1(3):179–184.
  • Culleton S, Kwok S, Chow E. Radiotherapy for pain. Clin Oncol (R Coll Radiol). 2011;23(6):399–406.
  • Lutz S, Lo SS, Chow E, Sahgal A, Hoskin P. Radiotherapy for metastatic bone disease: current standards and future prospectus. Expert Rev Anticancer Ther. 2010;10(5):683–695.
  • Caissie A, Zeng L, Nguyen J, Assessment of health-related quality of life with the European organization for research and treatment of cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases. Clin Oncol (R Coll Radiol). Mar 2012;24(2):125–133.
  • Caissie A, Culleton S, Nguyen J, EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer. 2012;20(4):841–848.
  • Tharmalingam S, Chow E, Harris K, Hird A, Sinclair E. Quality of life measurement in bone metastases: a literature review. J Pain Res. 2008;1:49–58.
  • Donato V, Cianciulli M, Crescenzi M, Monaco A, Caruso C, Morrone A. Rapid palliative radiotherapy unit: multidisciplinary management of bone metastases. Radiol Med. 2012;117(6):1071–8.
  • Andrade RS, Proctor JW, Slack R, Marlowe U, Ashby KR, Schenken LL. A simple and effective daily pain management method for patients receiving radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys. 2010;78(3):855–859.
  • Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9.
  • Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol. 1998;47(3):233–240.
  • Rasmusson B, Vejborg I, Jensen AB, Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol. 1995;34(3):179–184.
  • Chow E. Update on radiation treatment for cancer pain. Curr Opin Support Palliat Care. 2007;1(1):11–15.
  • Amouzegar-Hashemi F, Behrouzi H, Kazemian A, Zarpak B, Haddad P. Single versus multiple fractions of palliative radiotherapy for bone metastases: a randomized clinical trial in Iranian patients. Curr Oncol. 2008;15(3):36–39.
  • Foro Arnalot P, Fontanals AV, Galceran JC, Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008;89(2):150–155.
  • Kaasa S, Brenne E, Lund JA, Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. Radiother Oncol. 2006;79(3):278–284.
  • Steenland E, Leer JW, van Houwelingen H, The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch bone metastasis study. Radiother Oncol. 1999;52(2):101–109.
  • Kal HB. Single fraction radiotherapy is as effective as multiple fractions for palliating painful bone metastases. Cancer Treat Rev. 2003;29(4):345–347.
  • Arcangeli G, Giovinazzo G, Saracino B, D'Angelo L, Giannarelli D, Micheli A. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys. 1998;42(5):1119–1126.
  • Hartsell WF, Scott CB, Bruner DW, Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97(11):798–804.
  • Konski A, Desilvio M, Hartsell W, Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14. Int J Radiat Oncol Biol Phys. 2006;66(1):229–233.
  • Wu JS, Wong R, Johnston M, Bezjak A, Whelan T. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):594–605.
  • Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of randomised trials. Clin Oncol (R Coll Radiol). 2003;15(6):345–352.
  • Gripp S, Mjartan S, Boelke E, Willers R. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Cancer. 2010;116(13):3251–3256.
  • Fujino M, Suzuki K, Nishio M, Nishiyama N, Osaka Y. Strategy of radiation therapy for bone metastases and MSCC in breast cancer patients. Breast Cancer. 2011;18(4): 238–243.
  • van den Hout WB, van der Linden YM, Steenland E, Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst. 2003;95(3): 222–229.
  • Konski A. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys. 2004;60(5):1373–1378.
  • Konski A, James J, Hartsell W, Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol. 2009;32(4):423–428.
  • Shakespeare TP, Lu JJ, Back MF, Liang S, Mukherjee RK, Wynne CJ. Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol. 2003;21(11):2156–2162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.